For the first time, AstraZeneca has admitted that its COVID vaccine can cause a deadly blood clot side effect known as Thrombosis with Thrombocytopenia Syndrome (TTS).
The Vaxzevria (AstraZeneca) is no longer an approved COVID-19 vaccine, the Australian Government Department of Health and Aged Care announced last month.
A British public health study has found protection from either of the two most commonly used COVID-19 vaccines against the Delta variant of the coronavirus weakens within three months.
AstraZeneca has come out in defence of its vaccine for all adults after Australia's national medical panel again changed its advice for people in Sydney.
The federal government will send thousands of extra Pfizer vaccine doses to NSW to help douse Sydney's COVID-19 outbreak, as the prime minister hails a "record day" of jabs.
In the face of changing eligibility for the AstraZeneca vaccine, new variants of the coronavirus and supply constraints, many people are wondering whether they can “mix and match” COVID-19 vaccines.
The rollout of the AstraZeneca vaccine in Canberra is set to begin sooner than expected and will be administered at the same location as the Pfizer jab.
